2021 American Transplant Congress Archives

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

10:50am-11:00am: Superior Post-transplant Clinical Outcomes Using Portable Normothermic Perfusion and Assessment with the Organ Care System (ocs) Liver System: 1-year Outcomes of the Ocs Liver Protect Randomized Controlled Trial

J. Markmann¹, M. Abouljoud², M. Ghobrial³, C. Bhati⁴, S. Pelletier⁵, J. Magliocca⁶, T. Pruett⁷, A. Lu⁸, M. Rizzari⁹, S. Ottmann¹⁰, T. Klair¹¹, C. Eymard¹², G. Roll¹³, G. Reyes¹⁴, S. Black¹⁵, S. Florman¹⁶, S. Mirani¹⁷, C. Marsh¹⁸, G. Schnickel¹⁹, M. Kinkhabwala²⁰, A. Demetris²¹, H. Yeh²², P. Vagefi²³, M. MacConmara²³

Plenary 4 • Virtual

11:00am-11:10am: Novel Discovery of Super-antigen That Mobilize Regulatory Cd8 T Cells Inhibits Donor-specific Antibody and Protects Heart Allografts from Antibody-mediated Rejection

J. Y. Choi¹, H. Nakagawa², Z. Solhjou¹, K. Yatim¹, H. Zhang³, P. Patel³, M. Tawfeek Mohammed³, L. Riella⁴, H. Kim², H. Cantor², J. Azzi¹

Plenary 4 • Virtual

11:10am-11:20am: Extreme Phenotype Sampling and Next Generation Sequencing to Identify Genetic Variants Associated with Tacrolimus Metabolism in African American Kidney Transplant Recipients

C. R. Dorr¹, B. Guo², B. Wu², J. Abrahante², D. Schladt³, R. Remmel², W. Guan², A. Muthusamy³, G. Onyeaghala³, N. Pankratz², A. Matas², R. Mannon⁴, W. Oetting², P. Jacobson², A. K. Israni³

Plenary 4 • Virtual

11:20am-11:30am: Role of Ferroptosis Inhibitors in Mitigating Ischemia-Reperfusion Injury in Marginal Livers Using a Novel Protect Model

M. D. Nazzal, J. Van Nispen, A. Armstrong, V. Murali, E. Song, M. Voigt, A. Samaddar, E. Madsen, C. Manithody, J. Krebs, D. Blackall, D. Carpenter, C. Varma, J. Teckman, A. Jain

Plenary 4 • Virtual

4:30pm-4:35pm: A Fresh Look at Urbanicity and Its Impact on Additions to the Kidney and Liver Transplant Wait Lists

W. R. Johnson, S. A. Rega, I. D. Feurer, S. J. Karp

Disparities in Access and Machine Learning Outcomes in Solid Organ Transplantation • Virtual

4:30pm-4:35pm: A Meta-Analysis of Endoscopic Stents in the Treatment of Anastomotic Biliary Strictures After Liver Transplantation

F. Zhou¹, M. Mieth¹, C. Rupp², A. Mehrabi¹, A. Nickkholgh¹

Post Liver Transplant Management and Complications • Virtual

4:30pm-4:35pm: DSA Causes Mild Molecular ABMR-like Changes in Many Biopsies Not Diagnosed as Rejection

P. F. Halloran¹, K. S. Madill-Thomsen¹, &. the INTERCOMEX Study Group²

Kidney Antibody Mediated Rejection • Virtual

4:30pm-4:35pm: Lymphotoxin Beta Receptor Regulates Treg Migration and Suppression by Modulating Draining Lymphatic Structure

V. Saxena¹, W. Piao¹, L. Li¹, M. W. Shirkey¹, J. Iyyathurai¹, R. Lakhan¹, R. Abdi², J. Bromberg¹

Biomarkers and Cellular Therapies • Virtual

4:30pm-4:35pm: The Relationship Between Health Literacy and Adverse Outcomes After Kidney Transplantation

E. Lorenz, T. Petterson, C. Schinstock, W. Sanchez, K. Yost

Kidney Psychosocial • Virtual

4:35pm-4:40pm: Beyond Microarrays: Insights from Ncounter Transcript Analysis of Routine Archival Kidney Allograft Biopsies

I. Rosales, K. Tomaszewski, A. Milagros, T. Kawai, R. Smith, R. Colvin

Kidney Antibody Mediated Rejection • Virtual